SCHEMBL23777971

SCHEMBL23777971

CC(C)CC(N)C(=O)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1897992 1.00
SCHEMBL23777966 0.78 SLC1A3 (0.39)
SCHEMBL1146636 0.77 SLC1A3 (0.47)
SCHEMBL2617107 0.76
Leucine SCHEMBL331557 0.76 SLC7A5 (1.00)
Leucine SCHEMBL2478164 0.76 SLC7A5 (1.00)
Leucine SCHEMBL8568063 0.76 SLC7A5 (1.00)
Leucine SCHEMBL25241602 0.76 SLC7A5 (1.00)
D-Leucine SCHEMBL42012 0.76
Leucine SCHEMBL3888 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322743-A1 NOVEL SAFRYLAMINE DERIVATIVES HAVING PRODRUG PROPERTIES MIHKAL GMBH (CH) 2023-10-12 US disclosed
EP-3875590-A1 METHOD FOR PRODUCING ORGANIC COMPOUND AND CORYNEFORM BACTERIUM Green Earth Institute Co., Ltd. (JP) 2021-09-08 EP disclosed